Cefazolinum natricum - search results

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cefazoline noridem 1 g inj./inf. sol. (pwdr.) i.v. vial

noridem enterprises ltd. - cefazolin sodium 1,048 g - eq. cefazolin 1 g - powder for solution for injection/infusion - 1 g - cefazolin sodium 1.048 g - cefazolin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cefazoline noridem 2 g inj./inf. sol. (pwdr.) i.v. vial

noridem enterprises ltd. - cefazolin sodium 2,096 g - eq. cefazolin 2 g - powder for solution for injection/infusion - 2 g - cefazolin sodium 2.096 g - cefazolin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cefazoline sandoz 1 g inj. sol. (pwdr.) i.m./i.v. vial

sandoz sa-nv - cefazolin sodium 1048 mg - eq. cefazolin 1000 mg - powder for solution for injection - 1 g - cefazolin sodium 1048 mg - cefazolin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cefazoline sandoz 2 g inj. sol. (pwdr.) i.m./i.v. vial

sandoz sa-nv - cefazolin sodium 2096 mg - eq. cefazolin 2000 mg - powder for solution for injection - 2 g - cefazolin sodium 2096 mg - cefazolin

Australia - English - Department of Health (Therapeutic Goods Administration)

cefazolin-aft cefazolin sodium 2 g powder for injection vial

aft pharmaceuticals pty ltd - cefazolin sodium, quantity: 2.097 mg - injection, powder for - excipient ingredients: - treatment of the following serious infections due to susceptible organisms: ? respiratory tract infections due to strep. pneumoniae, klebsiella sp., h. influenzae, staph. aureus (penicillin sensitive and penicillin resistant) and group a beta-haemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. ? genitourinary tract infections due to e. coli, p. mirabilis, klebsiella sp. and some strains of enterobacter and enterococci. ? skin and skin structure infections due to staph. aureus (penicillin sensitive and penicillin resistant) and group a beta-haemolytic streptococci and other strains of streptococci. ? bone and joint infections due to staph. aureus. ? septicaemia due to strep. pneumoniae, staph. aureus (penicillin sensitive and penicillin resistant), p. mirabilis, e. coli and klebsiella sp. ? endocarditis due to staph. aureus (penicillin sensitive and penicillin resistant) and group a beta-haemolytic streptococci. ? appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefazolin